The alarming findings of a recent study from Norway have ignited serious concerns regarding the long-term safety of COVID-19 mRNA vaccines. Led by Professor Jarle Aarstad from the Western Norway ...

With the rise of omicron came the fall of long-lasting protection from reinfection with the pandemic coronavirus SARS-CoV-2, ...

Further, Moderna is working on a cancer vaccine in partnership with Merck. In this case, the mRNA grabs onto a specific target bespoke to each patient's cancer. The companies are testing the cancer ...

EVA Pharma of Africa, DNA Script and Quantoom Biosciences have signed a memorandum of understanding (MoU) to establish the first digital-to-biologics, end-to-end mRNA production platform in Egypt. It ...

While some of the initial zeal around localized vaccine production in Africa has waned since the height of the COVID-19 pandemic, efforts to bolster the continent’s immunization autonomy—especially | ...

A nasal vaccine for COVID-19 – based on technology developed at Washington University in St. Louis – is poised to enter a phase 1 clinical trial in the U.S. after an investigational new drug ...

A research team has developed a biodegradable polymer-based delivery system that efficiently transports mRNA.

Researchers uncover key mechanisms in gene regulation that may lead to better design of RNA-based medicines.